The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with ...

Semaglutide — known by brand names Ozempic and Wegovy — works in the brain to impact satiety. Over the past two years, the ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Italy: A recent multicentre real-world study supports the long-term effectiveness of once-weekly semaglutide as a valuable ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Ready to transform your body? It's possible with this program's personalized care, telehealth consultations, and semaglutide ...